Assyro AI

FDA Orange Book · active-ingredient family

Mebendazole

Mebendazole is approved as 2 brand and 1 generic application in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:VERMOX · NDA 208398

2

Brand (NDA)

1

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · tablet, chewable

ProductApplicantApplicationTEApproved
VERMOXRLDJANSSEN PHARMSNDA 208398Oct 19, 2016
VERMOXRLDJANSSEN PHARMSNDA 017481Approved Prior to Jan 1, 1982

Generic (ANDA) products (1)

ProductApplicantApplicationTEApproved
EMVERMIMPAX LABS INCANDA 073580Jan 04, 1995

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Mebendazole — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.